scholarly journals ADVANCE in context: The benefits, risks and feasibility of providing intensive glycaemic control based on gliclazide modified release

2020 ◽  
Vol 22 (S2) ◽  
pp. 5-11 ◽  
Author(s):  
Sophia Zoungas











The Lancet ◽  
2015 ◽  
Vol 385 (9974) ◽  
pp. 1180
Author(s):  
Tetsuro Tsujimoto ◽  
Ritsuko Yamamoto-Honda




Sign in / Sign up

Export Citation Format

Share Document